Echocardiographic Findings in Heart Failure Patients With Methamphetamine Use: A Case-Control Study.
diastolic dysfunction
echo
heart failure with reduced ejection fraction
methamphetamine induced cardiomyopathy
transoesophageal echo
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
accepted:
04
07
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
Background Methamphetamine use is associated with cardiovascular disease and significant morbidity and mortality. There is only one previous study performed on echocardiographic parameters in patients with methamphetamine cardiomyopathy. Methods We performed a retrospective review of medical records in a county hospital in Southern California with a high population of methamphetamine users. We reviewed medical records and echocardiogram findings in patients seen in our institution from November 2019 to November 2020 who had cardiomyopathy with and without methamphetamine use. We excluded patients who either left the hospital or expired before appropriate assessment. We divided our patient population into a case group (methamphetamine users) and a control group (non-methamphetamine users) to study and compare their echocardiographic parameters. Results Case group included a total of 254 patients and control group included 268 patients. Majority of the patient population were males - 178 (70%) and 180 (67%) in the case and control group respectively. Age was found to be statistically significant with the younger population in the case group (p = 0.0000). Our analysis revealed statistically significant difference in methamphetamine users compared to non-users in regards to left ventricle ejection fraction (33.65% ± 18.02 vs. 41.55% ± 15.61, p=0.0000), left ventricle mass index (122.49 grams/m
Identifiants
pubmed: 34268059
doi: 10.7759/cureus.16170
pmc: PMC8262112
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e16170Informations de copyright
Copyright © 2021, Jariwal et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Am Coll Cardiol. 1992 Nov 1;20(5):1168-74
pubmed: 1401618
JACC Heart Fail. 2017 Jun;5(6):435-445
pubmed: 28571597
Med Sci Law. 2003 Jul;43(3):267-71
pubmed: 12899434
Am J Cardiol. 1992 Jun 15;69(19):1549-52
pubmed: 1598868
J Am Coll Cardiol. 2004 Jun 16;43(12):2207-15
pubmed: 15193681
Clin Cardiol. 2009 Jun;32(6):E18-22
pubmed: 19330818
J Neurosci Res. 2016 Feb;94(2):170-8
pubmed: 26568405
Circulation. 2016 Dec 6;134(23):e579-e646
pubmed: 27832612
Heart Lung Circ. 2016 Apr;25(4):325-32
pubmed: 26706652
J Am Heart Assoc. 2020 Jun 2;9(11):e016704
pubmed: 32468897
Scand Cardiovasc J. 2010 Feb;44(1):24-30
pubmed: 19626561
Ann Intern Med. 1991 Mar 1;114(5):345-52
pubmed: 1825164
Life Sci. 2002 Jul 12;71(8):953-65
pubmed: 12084392
Cardiovasc Res. 2010 Jul 1;87(1):111-8
pubmed: 20139112
Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1739-1746
pubmed: 31433698
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
J Neurol Sci. 2016 Nov 15;370:107-111
pubmed: 27772737
N Z Med J. 2019 Sep 20;132(1502):55-66
pubmed: 31563927